In exploring the mechanism behind the enhanced cancer cellular uptake of the prepared conjugates, we thought that the native receptors of the proteins may play very limited roles, as albumin and RBD bind to different receptors (e.g., SPARC/gp60 for albumin and ACE2 for RBD). The gene discussed is SPARC; the disease is cancer.